Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2022)
Tg Therapeutics' (TGTX) quarterly Amortizatization of Intangibles came in at $23000.0 in Q1 2022, down 81.89% year-on-year from $127000.0 in Q1 2021, and down 76.04% quarter-over-quarter from $96000.0 in Q4 2021.
Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2022) Analysis & Trends
Tg Therapeutics' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $23000.0 for Q1 2022.
- On a quarterly basis, Amortizatization of Intangibles fell 81.89% year-over-year to $23000.0 in Q1 2022; TTM through Mar 2022 was $413000.0, a 603.66% increase from a year earlier, with the FY2021 full-year figure at $517000.0, changed N/A from the prior year.
- Amortizatization of Intangibles retreated to $23000.0 in Q1 2022 per TGTX's latest filing, from $96000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $155000.0 in Q2 2021 and bottomed at -$75000.0 in Q1 2019.
- The 4-year median for Amortizatization of Intangibles is -$4500.0 (2018), against an average of $17666.7.
- Biggest YoY gain for Amortizatization of Intangibles was 42.86% in 2019; the steepest drop was 3850.0% in 2019.
- Year by year, Amortizatization of Intangibles stood at -$68000.0 in 2018, then increased by 11.76% to -$60000.0 in 2019, then soared by 260.0% to $96000.0 in 2021, then tumbled by 76.04% to $23000.0 in 2022.
- Per Business Quant, the three latest TGTX Amortizatization of Intangibles figures stand at $23000.0 (Q1 2022), $96000.0 (Q4 2021), and $139000.0 (Q3 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | 127,000.00 |
| Mar 31, 2021 | 127,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Jun 30, 2019 | -74,000.00 |
| Jun 30, 2019 | -74,000.00 |
| Mar 31, 2019 | -75,000.00 |
| Mar 31, 2019 | -75,000.00 |
| Dec 31, 2018 | -68,000.00 |
| Dec 31, 2018 | -68,000.00 |
| Sep 30, 2018 | -42,000.00 |
| Sep 30, 2018 | -42,000.00 |